reviewed april 2026|next review october 2026|88 physicians psi has verified|149 published studies
Copper Peptides
Copper peptides are a family of peptides that bind and deliver copper ions to biological tissues, with GHK-Cu as the most extensively studied member (186 published studies, 4,000+ genes modulated), encompassing alanyl-histidyl-lysine copper (AHK-Cu, hair research), DAHK (copper transport), and various commercial formulations.
Evidence landscape: 149 published studies
149 published items. 1 human study and 142 animal studies.
- 1 Human
- 142 Animal
- 6 Reviews
This page covers the broader copper peptide family. GHK-Cu, the most studied individual member, has a dedicated page. Evidence depth varies dramatically across family members, from 186 studies (GHK-Cu) to zero.
Copper peptides deliver Cu2+ to activate copper-dependent enzymes: lysyl oxidase (collagen cross-linking), superoxide dismutase (antioxidant defense), and tyrosinase (melanin synthesis). The copper delivery mechanism is the shared feature across all family members.
GHK-Cu has 186 published studies and documented modulation of 4,000+ genes. AHK-Cu has cell culture hair growth data only. DAHK has copper transport biochemistry. Other variants have minimal or no independent evidence.
PSI Assessment
This is a family page covering all copper peptides. The evidence depth varies dramatically across family members. GHK-Cu is the research benchmark with 186 published studies and documented modulation of 4,000+ genes across wound healing, anti-aging, and anti-inflammatory applications. AHK-Cu is marketed for hair growth but has only cell culture data. DAHK is a copper transport biochemistry compound. Other commercial variants have minimal or no independent evidence. Copper-dependent enzymes (lysyl oxidase, superoxide dismutase, tyrosinase) are essential for tissue repair, and copper peptides deliver bioavailable copper to activate these enzymes.
GHK-Cu is the research benchmark with 186 studies and 4,000+ gene modulation. Evidence depth varies dramatically across family members, from 186 studies to zero.
Copper peptides are a family of peptides that bind and deliver copper(II) ions to biological tissues. The shared mechanism is copper delivery to activate metalloenzymes: lysyl oxidase for collagen cross-linking, superoxide dismutase for antioxidant defense, and tyrosinase for melanin synthesis. GHK-Cu is the anchor compound with the deepest evidence base (186 studies, 4,000+ gene modulation). AHK-Cu (Ala-His-Lys) is studied for hair follicle stimulation in cell culture. DAHK (Asp-Ala-His-Lys) is the N-terminal albumin tetrapeptide studied for copper transport biochemistry. Palmitoyl tripeptide-1 uses the GHK backbone without copper for signal peptide activity. The family combines metalloenzyme activation (copper delivery) with matrikine signaling (peptide sequence-specific effects).
What the evidence supports
Copper is essential for enzymes that drive tissue repair (lysyl oxidase, superoxide dismutase, tyrosinase). GHK-Cu is the most extensively studied copper peptide with 186 published studies and documented modulation of over 4,000 genes. Topical copper peptide products have decades of cosmetic use history. The copper delivery mechanism is pharmacologically characterized.
What is not yet established
Whether copper peptides other than GHK-Cu deliver meaningful biological effects beyond copper delivery. Whether topical copper peptide application reaches therapeutic concentrations in target tissues. Head-to-head comparisons between family members (GHK-Cu vs AHK-Cu vs DAHK). Whether injectable copper peptides produce systemic effects beyond what topical application achieves.
Research Evidence
The findings below cover the family-level copper biology, the GHK-Cu benchmark, and the evidence disparity across family members.
Evidence by condition
Evidence dimensions across the copper peptide family. GHK-Cu drives the strongest evidence across all conditions. Other family members have substantially thinner evidence bases.
| Condition | Mechanism | Animal evidence | Human evidence | Replication |
|---|---|---|---|---|
| Skin Health/Anti-Aging | ||||
| Wound Healing | ||||
| Hair Growth | ||||
| Copper Biology |
GHK-Cu is the most extensively studied copper peptide with 186 published studies. Transcriptomic analysis shows modulation of over 4,000 human genes spanning tissue repair, inflammation, and antioxidant defense.
GHK-Cu's evidence base cannot be generalized to other family members. Each copper peptide has a different sequence, potentially different binding properties, and different biological activities beyond copper delivery.
Copper is essential for tissue repair enzymes. Lysyl oxidase requires copper for collagen cross-linking. Superoxide dismutase requires copper for antioxidant defense. This shared biology underlies all copper peptide applications.
The copper delivery mechanism is the family's common denominator. Whether different peptide sequences deliver copper with different efficiency or to different tissue targets is not well characterized.
Topical copper peptide products have decades of cosmetic use history with excellent safety profiles. They are among the most validated peptide ingredients in commercial skincare.
Commercial validation and safety history are genuine strengths of the copper peptide class. Clinical evidence depth varies significantly by specific compound.
1 Human|142 Animal|6 Reviews
View all 149 indexed studiesHow Copper Peptides Works
Copper peptides are a family of peptide-metal complexes that deliver bioavailable copper(II) ions to tissues, activating copper-dependent metalloenzymes (lysyl oxidase, superoxide dismutase, tyrosinase) while the peptide sequences provide matrikine or growth factor signaling.
Copper is essential for building collagen, healing wounds, and defending against oxidative damage. The body needs it delivered in a usable form. Copper peptides act as delivery vehicles, carrying copper directly to skin cells in a bioavailable form that cells can immediately use for repair and regeneration.
For a more detailed view of the biology, here is what researchers have observed at the molecular level.
Copper peptides coordinate Cu2+ ions via histidine residues, delivering bioavailable copper to tissues. This activates copper-dependent enzymes including lysyl oxidase (collagen crosslinking), superoxide dismutase (antioxidant defense), and matrix metalloproteinases (tissue remodeling). They stimulate collagen and glycosaminoglycan synthesis, promote angiogenesis, and modulate inflammatory responses.
What is Copper Peptides being studied for?
Researchers are studying Copper Peptides across several health conditions. Each condition below is labeled with the strength of evidence that exists for that specific use, not for Copper Peptides overall. This means a compound can have human studies for one condition but only animal data for another.
Skin Health/Anti-Aging
·Human TrialsTopical copper peptide studies show improved skin thickness, elasticity, and collagen density. GHK-Cu provides the strongest evidence base. Decades of commercial cosmetic use history.
Limitations: Head-to-head comparisons with retinoids or vitamin C are lacking. Most evidence is from GHK-Cu specifically. Generalization to other family members is not established.
Wound Healing
·Animal StudiesAnimal and laboratory studies show copper peptides accelerate wound closure through angiogenesis, collagen deposition, and anti-inflammatory activity.
Limitations: Large-scale controlled human wound-healing trials are limited. Most data is from animal models and small human studies.
Hair Growth
·PreclinicalAHK-Cu shows dermal papilla cell proliferation in cell culture. Theoretical basis exists for hair growth through copper-dependent follicle biology.
Limitations: No controlled human hair growth trials for any copper peptide. Claims are based on cell culture data and the theoretical role of copper in follicle biology.
Copper Biology
·Animal StudiesThe copper delivery and metalloenzyme activation mechanism is well-characterized. DAHK's copper transport role in albumin is established biochemistry.
Limitations: Understanding copper biology does not automatically validate specific copper peptide products. The gap between biochemistry and clinical application varies by family member.
Safety and Regulatory Status
FDA Status: Not regulated as drugs. Established cosmetic and medical product ingredients with decades of commercial history.
Availability: Widely available in over-the-counter skincare products. GHK-Cu injectable form was temporarily removed from legal pharmacy preparation by the FDA but is expected to return.
Class context: Family of copper-binding peptides. GHK-Cu is the flagship member with the deepest evidence. The family includes GHK-Cu, AHK-Cu, DAHK, and various commercial formulations.
Excellent topical safety profile with decades of commercial use. Copper peptide serums should not be combined simultaneously with L-ascorbic acid (vitamin C), as copper can oxidize vitamin C and reduce efficacy of both.
Peptide Structure
Technical molecular data for researchers and clinicians.
Questions and Comparisons
Questions the evidence raises for a Copper Peptides discussion.
Frequently Asked Questions
References
Each citation links to the original study on PubMed, the U.S. National Library of Medicine database.
- 1.Comprehensive review of the copper peptide family with focus on GHK-Cu, covering tissue repair mechanisms, gene expression modulation across 4,000+ genes, and the copper delivery function that is shared across the peptide family.Pickart L et al., 2012 in Oxid Med Cell Longev. View on PubMed
- 2.Meta-analysis of copper peptide efficacy in dermatological applications, covering collagen stimulation, wound healing acceleration, and the decades-long commercial safety record of topical copper peptide products.Badenhorst T et al., 2014 in Skin Pharmacol Physiol. View on PubMed
Medical Disclaimer
This content is for educational and informational purposes only and does not constitute medical advice. The information presented reflects published research as indexed by PSI and should not be used to make treatment decisions. Always consult a qualified healthcare provider before starting, stopping, or modifying any treatment.